Patient involvement in prostate cancer treatment decisions
Completed
- Conditions
- Prostate cancerCancer
- Registration Number
- ISRCTN97145188
- Lead Sponsor
- Dutch Cancer Society (The Netherlands)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Male
- Target Recruitment
- 300
Inclusion Criteria
Patients with prostate cancer referred for radiotherapy with curative intent are eligible.
Exclusion Criteria
Labile personality structure, as assessed by the physicians, and lack of understanding of the Dutch language.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome measure is choice acceptance. At the end of the interview, the patient is asked whether he wants to choose one of the two treatment options, or whether he wants to leave the decision to the physician. The response to this question is choice acceptance. Choice acceptance is confirmed by telephone 2 days later. This measure is obtained about 10 days after the first consultation.
- Secondary Outcome Measures
Name Time Method 1. Substitute preferences of physicians <br>2. Quality of life measures<br>3. Decision evaluation measures <br>4. Coping measures<br>5. Knowledge measures <br>6. Treatment preferences